- Home
- CCM vs LRE Comparison
CCM vs LRE Comparison
Compare CCM & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- LRE
- Stock Information
- Founded
- CCM 1997
- LRE 2001
- Country
- CCM China
- LRE Japan
- Employees
- CCM N/A
- LRE N/A
- Industry
- CCM Medical/Nursing Services
- LRE
- Sector
- CCM Health Care
- LRE
- Exchange
- CCM Nasdaq
- LRE Nasdaq
- Market Cap
- CCM 18.2M
- LRE 17.6M
- IPO Year
- CCM 2009
- LRE 2023
- Fundamental
- Price
- CCM $8.20
- LRE $1.20
- Analyst Decision
- CCM
- LRE
- Analyst Count
- CCM 0
- LRE 0
- Target Price
- CCM N/A
- LRE N/A
- AVG Volume (30 Days)
- CCM 67.4K
- LRE 10.4K
- Earning Date
- CCM 05-23-2025
- LRE 01-01-0001
- Dividend Yield
- CCM N/A
- LRE N/A
- EPS Growth
- CCM N/A
- LRE N/A
- EPS
- CCM N/A
- LRE 0.29
- Revenue
- CCM $52,603,198.00
- LRE $117,804,154.00
- Revenue This Year
- CCM N/A
- LRE N/A
- Revenue Next Year
- CCM N/A
- LRE N/A
- P/E Ratio
- CCM N/A
- LRE $4.10
- Revenue Growth
- CCM N/A
- LRE 8.82
- 52 Week Low
- CCM $3.80
- LRE $1.10
- 52 Week High
- CCM $26.70
- LRE $13.76
- Technical
- Relative Strength Index (RSI)
- CCM 67.10
- LRE 46.94
- Support Level
- CCM $6.70
- LRE $1.22
- Resistance Level
- CCM $9.46
- LRE $1.29
- Average True Range (ATR)
- CCM 1.34
- LRE 0.12
- MACD
- CCM 0.16
- LRE -0.01
- Stochastic Oscillator
- CCM 66.60
- LRE 12.20
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
About LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment building units to individual customers in Japan and Dallas, Texas. Predominantly, its revenue is generated from developing and selling single-family homes and condominiums. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.